| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $332.6M | — | +26.5% |
| Cost of Revenue | $123.1M | — | +17.8% |
| Gross Profit | $209.5M | — | +32.3% |
| R&D Expense | $78.3M | — | +13.7% |
| SG&A Expense | $48.5M | — | +13.4% |
| Operating Income | $18.5M | — | +491.5% |
| Pre-tax Income | $24.5M | — |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $492.0M | -29.5% | -40.3% |
| Short-term Investments | $519.9M | +15.1% | +1.0% |
| Accounts Receivable | $94.6M | -32.7% | -2.9% |
| Current Assets | $1.36B | -10.0% | -17.1% |
| Total Assets | $2.64B | -3.0% | +1.6% |
| Current Liabilities |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$67.4M | — | -8.2% |
| Capital Expenditures | $4.9M | — | +478.6% |
| Investing Cash Flow | -$138.8M | — | -78.8% |
| Financing Cash Flow | $413K | — | -99.9% |
| Free Cash Flow | -$72.3M | — | -14.5% |
| +784.9% |
| Income Tax | -$6.8M | — | -6.8% |
| Net Income | $31.3M | — | +242.6% |
| EPS (Basic) | $0.37 | — | +236.4% |
| EPS (Diluted) | $0.36 | — | +227.3% |
| $389.9M |
| -28.4% |
| -36.6% |
| Total Liabilities | $1.11B | -12.5% | -16.8% |
| Stockholders' Equity | $1.53B | +5.2% | +20.9% |